Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 1
2009 1
2010 2
2011 1
2014 2
2015 2
2017 1
2018 1
2019 1
2021 1
2022 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized Trial.
Sáez-Llorens X, Norero X, Mussi-Pinhata MM, Luciani K, de la Cueva IS, Díez-Domingo J, Lopez-Medina E, Epalza C, Brzostek J, Szymański H, Boucher FD, Cetin BS, De Leon T, Dinleyici EC, Gabriel MÁM, Ince T, Macias-Parra M, Langley JM, Martinón-Torres F, Rämet M, Kuchar E, Pinto J, Puthanakit T, Baquero-Artigao F, Gattinara GC, Arribas JMM, Ramos Amador JT, Szenborn L, Tapiero B, Anderson EJ, Campbell JD, Faust SN, Nikic V, Zhou Y, Pu W, Friel D, Dieussaert I, Lopez AG, McPhee R, Stoszek SK, Vanhoutte N. Sáez-Llorens X, et al. Among authors: lopez ag. J Infect Dis. 2024 Jan 12;229(1):95-107. doi: 10.1093/infdis/jiad271. J Infect Dis. 2024. PMID: 37477875 Free PMC article. Clinical Trial.
RSV-A neutralizing titers and RSV F-binding antibody concentrations were higher post-ChAd155-RSV than postcomparator at days 31, 61, and end of RSV season 1 (mean follow-up, 7 months). High-dose ChAd155-RSV induced stronger responses than low-dose, with further increases p …
RSV-A neutralizing titers and RSV F-binding antibody concentrations were higher post-ChAd155-RSV than postcomparator at days 31, 61, and end …
Neurolymphomatosis in Recrudescent Diffuse Large B-cell Lymphoma.
Lopez AR, Sohani AR, O'Shea A, Ng TSC. Lopez AR, et al. Asia Ocean J Nucl Med Biol. 2023;11(1):89-92. doi: 10.22038/AOJNMB.2022.66666.1464. Asia Ocean J Nucl Med Biol. 2023. PMID: 36619186 Free PMC article.
MRI at that time demonstrated thickening and enhancement of the cauda equina nerve roots. Over the course of the subsequent eight months, he developed left lower extremity sensory symptoms, left-sided foot drop and signs of upper motor neuron involvement, including left fa …
MRI at that time demonstrated thickening and enhancement of the cauda equina nerve roots. Over the course of the subsequent eight months …
[Pre-extensively drug-resistant congenital tuberculosis: case report].
Castillo HD, Lopez AS, Temoche AP, Mosquera AS, Rojas TV. Castillo HD, et al. Among authors: lopez as. Rev Peru Med Exp Salud Publica. 2018 Oct-Dec;35(4):695-698. doi: 10.17843/rpmesp.2018.354.3647. Rev Peru Med Exp Salud Publica. 2018. PMID: 30726436 Free article. Spanish.
Tuberculosis in infants is a clinical case difficult to diagnose by regular testing which often yield negative results; additionally, the source of transmission is difficult to identify. This work presents the case of a one-month old nursing boy presenting irritability, ta …
Tuberculosis in infants is a clinical case difficult to diagnose by regular testing which often yield negative results; additionally, the so …
Blood pressure targets for the treatment of people with hypertension and cardiovascular disease.
Saiz LC, Gorricho J, Garjón J, Celaya MC, Muruzábal L, Malón MDM, Montoya R, López A. Saiz LC, et al. Among authors: lopez a. Cochrane Database Syst Rev. 2017 Oct 11;10(10):CD010315. doi: 10.1002/14651858.CD010315.pub2. Cochrane Database Syst Rev. 2017. PMID: 29020435 Free PMC article. Updated. Review.
SELECTION CRITERIA: We included randomized controlled trials (RCTs) with more than 50 participants per group and at least six months follow-up. Trial reports needed to present data for at least one primary outcome (total mortality, serious adverse events, total cardiovascu …
SELECTION CRITERIA: We included randomized controlled trials (RCTs) with more than 50 participants per group and at least six months …
ASSESSMENT OF OCCUPATIONAL EXPOSURE IN THE MAIN PAEDIATRIC INTERVENTIONAL RADIOLOGY PROCEDURES.
Morcillo AB, Huerga C, Bayón J, López A, Corredoira E, Hernández T, Novo JR, Ponce MD, Fernández L, Rodríguez R, Garzón G, Vañó E, Guibelalde E, Alejo L. Morcillo AB, et al. Among authors: lopez a. Radiat Prot Dosimetry. 2022 Jun 9;198(7):386-392. doi: 10.1093/rpd/ncac064. Radiat Prot Dosimetry. 2022. PMID: 35512690
The aim of this study is to evaluate the personal dose equivalent Hp(10) in the most frequent (non-cardiac) paediatric interventional radiology (PIR) procedures: central venous catheters (CVC), hepatic/biliary and sclerotherapy interventions. i2 active solid-state dosemeters plac …
The aim of this study is to evaluate the personal dose equivalent Hp(10) in the most frequent (non-cardiac) paediatric interventional radiol …
Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction.
Esteban-Fernández A, Gómez-Otero I, López-Fernández S, Santamarta MR, Pastor-Pérez FJ, Fluvià-Brugués P, Pérez-Rivera JÁ, López López A, García-Pinilla JM, Palomas JLB, Bonet LA, Cobo-Marcos M, Mateo VM, Llergo JT, Fernández VA, Vives CG, de Juan Bagudá J, Benedicto AM, de Polavieja JIM, Solla-Ruiz I, Solé-González E, Cardona M, Olaetxea JR, Cortés CO, Dosantos VM, López AG, Amao E, Sánchez BC, Torres EA, Carrillo VG, García-Fuertes D, Ridocci-Soriano F; TIDY-HF investigators. Esteban-Fernández A, et al. Among authors: lopez ag. Clin Res Cardiol. 2023 Jun 21. doi: 10.1007/s00392-023-02241-0. Online ahead of print. Clin Res Cardiol. 2023. PMID: 37341769
METHODS AND RESULTS: Prospective, observational, and multicenter registry that evaluated the treatment initiated in patients with newly diagnosed HFrEF and its evolution at 3 months. Clinical and analytical data were collected, as well as adverse reactions and events durin …
METHODS AND RESULTS: Prospective, observational, and multicenter registry that evaluated the treatment initiated in patients with newly diag …
The STatin Adverse Treatment Experience Survey: Experience of patients reporting side effects of statin therapy.
Jacobson TA, Cheeley MK, Jones PH, La Forge R, Maki KC, López JAG, Xiang P, Bushnell DM, Martin ML, Cohen JD. Jacobson TA, et al. Among authors: lopez jag. J Clin Lipidol. 2019 May-Jun;13(3):415-424. doi: 10.1016/j.jacl.2019.04.011. Epub 2019 May 18. J Clin Lipidol. 2019. PMID: 31113745
Respondents with self-reported high cholesterol who had taken a statin in the past 2 years and experienced 1 statin-associated symptom in the past 6 months were included (N = 1500). RESULTS: Mean age was 58 years, 40.3% were men, and 43.2% had tried 2 statins. ...
Respondents with self-reported high cholesterol who had taken a statin in the past 2 years and experienced 1 statin-associated symptom in th …
Patient Navigation After Positive Fecal Immunochemical Test Results Increases Diagnostic Colonoscopy and Highlights Multilevel Barriers to Follow-Up.
Cusumano VT, Myint A, Corona E, Yang L, Bocek J, Lopez AG, Huang MZ, Raja N, Dermenchyan A, Roh L, Han M, Croymans D, May FP. Cusumano VT, et al. Among authors: lopez ag. Dig Dis Sci. 2021 Nov;66(11):3760-3768. doi: 10.1007/s10620-021-06866-x. Epub 2021 Feb 20. Dig Dis Sci. 2021. PMID: 33609211
The primary intervention endpoint was completion of colonoscopy within 6 months of navigation. We documented reasons for persistent barriers to colonoscopy despite navigation and determined predictors of successful follow-up after navigation. RESULTS: There were 119 patien …
The primary intervention endpoint was completion of colonoscopy within 6 months of navigation. We documented reasons for persistent b …
Evolocumab Treatment in Pediatric Patients With Homozygous Familial Hypercholesterolemia: Pooled Data From Three Open-Label Studies.
Raal FJ, Hegele RA, Ruzza A, López JAG, Bhatia AK, Wu J, Wang H, Gaudet D, Wiegman A, Wang J, Santos RD. Raal FJ, et al. Among authors: lopez jag. Arterioscler Thromb Vasc Biol. 2024 May;44(5):1156-1164. doi: 10.1161/ATVBAHA.123.320268. Epub 2024 Mar 28. Arterioscler Thromb Vasc Biol. 2024. PMID: 38545781 Free PMC article.
Overall, median exposure to evolocumab was 18.2 (Q1, Q3: 3.0, 18.5) months. Treatment-emergent adverse events with an exposure-adjusted patient incidence rate of 5% were upper respiratory tract infection (6.6%), influenza (5.2%), and acne (5.0%) per 100 patient-years. ...
Overall, median exposure to evolocumab was 18.2 (Q1, Q3: 3.0, 18.5) months. Treatment-emergent adverse events with an exposure-adjust …
Application of Extra Virgin Olive Oil to Prevent Nipple Cracking in Lactating Women.
Cordero MJ, Villar NM, Barrilao RG, Cortés ME, López AM. Cordero MJ, et al. Among authors: lopez am. Worldviews Evid Based Nurs. 2015 Dec;12(6):364-9. doi: 10.1111/wvn.12113. Epub 2015 Nov 17. Worldviews Evid Based Nurs. 2015. PMID: 26574663
Clinical evaluations were made during the first week of treatment and after the first month. All women who initiated breastfeeding were considered eligible to be included in this study; breastfeeding was characterized as the moment of mother-child interaction with suction …
Clinical evaluations were made during the first week of treatment and after the first month. All women who initiated breastfeeding we …
18 results